Fourth DONES Users Workshop

Sesión

Life sciences and medical applications

14 oct 2026, 16:20

Main Auditorium (CIEMAT)

130. IFMIF-DONES role in Personalized Nuclear Medicine

Marta Oteo (CIEMAT)

14/10/26, 16:20

Nuclear medicine is moving steadily toward a personalized approach, driven by the development of Targeted Radionuclide Therapy (TRT) and theranostic strategies that allow diagnosis and treatment to be tailored to the molecular profile of each patient’s disease. TRT relies on radiolabeled compounds that accumulate selectively in tumors or other pathological tissue, delivering cytotoxic...

111. Radiobiology at DONES: Current Status and Future Perspectives

Cristina Méndez Malagón (Universidad de Granada)

14/10/26, 16:45

Studying the effects of neutrons on the human body is a topic of great current interest. Neutrons can be regarded as a double-edged sword: depending on the context, they may pose a health risk (in occupational environments, space missions, etc.) or serve as a therapeutic tool, as in treatments such as Boron Neutron Capture Therapy (BNCT).

Despite the significant scientific interest in...

112. High-Power Target Technology for Deuteron-Induced Medical Radioisotope Production at IFMIF-DONES

María Elena López Melero (University of Granada)

14/10/26, 17:00

The unique neutron environment available at IFMIF-DONES offers significant opportunities for life-science and medical applications, including radiobiological research, neutron-based therapies, and the production of radioisotopes for nuclear medicine. In particular, the growing demand for diagnostic and therapeutic radionuclides has motivated the exploration of innovative production routes that...